The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from the skin cancer cohorts.
 
Mark R. Middleton
Consulting or Advisory Role - BiolineRx; Bristol-Myers Squibb; Immunocore; Johnson & Johnson; Merck; Vaccitech; Vista Pharmacueticals
Research Funding - Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst); Vertex (Inst)
(OPTIONAL) Uncompensated Relationships - GenesisCare
 
Francesca Aroldi
Travel, Accommodations, Expenses - Nucana
 
Joseph Sacco
Honoraria - Amgen; Bristol-Myers Squibb; Immunocore; MSD; Pierre Fabre
Consulting or Advisory Role - Delcath Systems; Immunocore; MSD
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); MSD (Inst); Replimune (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Mohammed M. Milhem
Honoraria - Amgen; Array BioPharma; Blueprint Medicines; Immunocore; Novartis; Trieza Therapeutics
Consulting or Advisory Role - Amgen; Array BioPharma; Blueprint Medicines; Immunocore; Novartis; Trieza Therapeutics
Research Funding - Amgen (Inst); E.R. Squibb Sons, LLC (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst)
 
Brendan D. Curti
Honoraria - Bristol-Myers Squibb; Replimune
Consulting or Advisory Role - Eisai; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); Prometheus (Inst); Viralytics (Inst)
Patents, Royalties, Other Intellectual Property - Biomarkers for OX40 response (Inst)
Travel, Accommodations, Expenses - Agonox
 
Ari M. Vanderwalde
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Life Sciences; Caris Life Sciences; Compugen; Concerto HealthAI; Elsevier; Genentech/Roche; Immunocore
Research Funding - Amgen (Inst); Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Caris Life Sciences (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Polynoma (Inst); Replimune (Inst)
 
Scott Baum
No Relationships to Disclose
 
Adel Samson
Research Funding - Transgene (Inst)
 
Anna C. Pavlick
Honoraria - Array BioPharma; Bristol-Myers Squibb; Regeneron; Sanofi; Seagen
Consulting or Advisory Role - Regeneron; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Regeneron (Inst); Replimune (Inst)
Travel, Accommodations, Expenses - Regeneron; Seagen
 
Jason Alan Chesney
Consulting or Advisory Role - Amgen; Replimune
Research Funding - Amgen; Bristol-Myers Squibb; Iovance Biotherapeutics; MedImmune; Replimune
Patents, Royalties, Other Intellectual Property - University of Louisville US Patents
Travel, Accommodations, Expenses - Amgen; Replimune
 
Jiaxin Niu
No Relationships to Disclose
 
Terence Duane Rhodes
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb; Merck
 
Tawnya Lynn Bowles
Research Funding - Amgen (Inst); Genentech (Inst); Idera (Inst); MAVIS (Inst); Replimune (Inst)
 
Anna Olsson-Brown
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Lilly (Inst); Novartis; Roche (Inst); UCB (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; SERVIER
 
Douglas Earl Laux
No Relationships to Disclose
 
Praveen Bommareddy
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Alex Deterding
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Joseph Elassal
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Robert S. Coffin
Employment - Replimune
Leadership - Replimune
Stock and Other Ownership Interests - Replimune
Research Funding - Replimune
 
Kevin Harrington
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; MSD; Oncolys BioPharma; Pfizer; Replimune
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; MSD; Oncolys BioPharma; Pfizer; Replimune
Research Funding - AstraZeneca; Boehringer Ingelheim; MSD; Replimune